An in-depth look to ACTIVE BIOTECH AB operating, investing, and financing activities

ACTI free cash flow for Q3 24 is -7.2 M SEK. For 2023, ACTI free cash flow was -45.74 M SEK and operating cash flow was -45.74 M SEK.